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Mark A. Lemleyt & Ziv Shafirtt
Economists and legal scholars have debated the reasons people adopt open-
source software, and accordingly whether and to what extent the open-source model
can scale, replacing proprietary rights as a primary means of production. In this Article,
we use the release by a biotechnology company of similar software under both proprie-
tary and open-source licenses to investigate who uses open-source software and why.
We find that academic users are somewhat more likely to adopt open-source software
than private firms. We find only modest differences in the willingness of open-source
users to modify or improve existing programs. And we find that users of open-source
software often make business decisions that seem indifferent to the norms of open-
source distribution. Our findings cast some doubt on the penetration of the open-source
ethos beyond traditional software markets.
I. BACKGROUND
The traditional theory of intellectual property (IP) is well under-
stood. Creators of intellectual content would have insufficient incen-
tive to create if their works could be cheaply and quickly imitated.
Thus, the law grants legal control over new creations in order to pre-
vent, delay, or raise the cost of imitation and therefore encourage in-
vestment in creation.
The rise of open-source software poses an important challenge to
the classic account of the production of intellectual public goods. In-
stead of using IP rights to optimize monetary benefit, open-source
production relies on IP rights to keep software, and any improve-
ments or additions to it, free and widely accessible. Open-source soft-
ware is provided to others for free; providers profit, if at all, not by
selling the software or improvements to it but by providing consulting
or other services.
Scholars vigorously debate whether open-source software repre-
sents a fundamental new means of collaborative production potentially
extendable to other forms of human endeavor2 or an altruistic fringe
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1 See Mark A. Lemley, The Economics of Improvement in Intellectual Property Law, 75
Tex L Rev 989,993-1000 (1997).
2 See Christopher M. Kelty, Two Bits: The Cultural Significance of Free Software 66-79
(Duke 2008); Yochai Benkler, The Wealth of Networks 219-33 (Yale 2006).
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to the dominant market-based model of production. For economists
in particular, this debate is intimately bound up with questions about
the motivations of those who participate in open-source production. If
the classic theory of IP holds-if people are rational economic actors
who will create only if the expected rewards exceed the costs-then
open-source production is likely to be limited to the creation of rela-
tively low-cost or small-scale products, primarily by those who do it in
their spare time out of altruism or intellectual curiosity or who are
otherwise subsidized (perhaps by a government or university) to cre-
ate software without being paid for it.4 By contrast, if people are col-
lectively motivated to create by nonfinancial incentives, or if there is a
sustainable market for the provision of services ancillary to open-
source products,' the open-source model could conceivably displace
proprietary software and even extend to products other than software,
such as DNA databases.'
The economic literature has made substantial strides in trying to
explain and characterize the free and open software movement. Expla-
nations focus on social norms and ethics that reward contributors in
nonmonetary ways (for example by enhancing reputation in a comm-
unity),' on the unique characteristics of software as a network good and
the corresponding possibility of monetizing services or ancillary prod-
ucts,8 or on expected benefits from private learning or from reciprocal
3 See Andrew George, Avoiding Tragedy in the Wiki-Commons, 12 Va J L & Tech 1,
In 8-9 (Fall 2007); Ronald J. Mann, Commercializing Open Source Software: Do Property Rights
Still Matter?, 20 Hary J L & Tech 1, 24-25 (2006); Andrea Bonaccorsi and Cristina Rossi, Altru-
istic Individuals, Selfish Firms? The Structure of Motivation in Open Source Software, 9 First
Monday 5 (Jan 2004), online at http://firstmonday.org/htbin/cgiwrap/bin/ojs/index.php/fm/article/
view/1113/1033 (visited Oct 18, 2010) (showing that altruism is a motivating factor for individual
programmers); David McGowan, Legal Implications of Open-Source Software, 2001 U Ill L Rev
241,260-62.
4 See Jan Eilhard, Open Source Incorporated *52-55 (unpublished manuscript, Feb 2009),
online at http://ssrn.com/abstract=1360604 (visited Oct 18, 2010).
5 See Michele Boldrin and David K. Levine, Market Structure and Property Rights in
Open Source Industries, 30 Wash U J L & Pol 325, 330-33 (2009); James Bessen, Open Source
Software: Free Provision of Complex Public Goods, in Jiurgen Bitzer and Philipp J.H. Schrdeder,
eds, The Economics of Open Source Software Development 57,79-80 (Elsevier 2006).
6 See Andrew W. Torrance, Open Source Human Evolution, 30 Wash U J L & Pol 93,
125-28 (2009); Stephen M. Maurer, Arti Rai, and Andrej Sali, Finding Cures for Tropical Dis-
eases: Is Open Source an Answer?, 6 Minn J L, Sci, & Tech 169, 171 (2004).
7 See Josh Lerner and Jean Tirole, Some Simple Economics of Open Source, 52 J Indust
Econ 197, 212-15 (2002); Josh Lerner and Jean Tirole, The Open Source Movement: Key Re-
search Questions, 45 Eur Econ Rev 819, 822-23 (2001); Eric S. Raymond, The Cathedral and the
Bazaar 64-66 (O'Reilly 1999).
8 See Stephen M. Maurer and Suzanne Scotchmer, Open Source Software: The New Intel-
lectual Property Paradigm, in Terrance Hendershott, ed, Economics and Information Systems
285, 290-92 (Elsevier 2006); Mann, 20 Hary J L & Tech at 33-34 (cited in note 3); Robert P.
Merges, A New Dynamism in the Public Domain, 71 U Chi L Rev 183, 192-93 (2004); Yochai
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contribution by others.! It has also emphasized that roughly half of all
open-source contributors are paid for their contribution, usually by
corporate sponsors," though that raises the question of why the corpo-
rations are willing to pay that money.
Critical to advancing this debate is understanding who chooses
open-source software and why.
II. OUR STUDY
In this study, we take advantage of a natural experiment in the
provision of software in the bioinformatics industry to test motiva-
tions and usage patterns for open-source and proprietary software.
Affymetrix, a company that sells microarrays (branded as
"GeneChips") for use in DNA-based laboratory tests, provides soft-
ware that enables purchasers to use the chips and analyze the results."
Specifically, Affymetrix and other companies have developed several
algorithms that summarize the chip probe-set results and normalize
the resulting data, allowing users of the Affymetrix GeneChip to ana-
lyze and understand the results of the chip probes. They have in turn
implemented these algorithms in a variety of software programs.
Importantly, Affymetrix makes available both open-source and
proprietary versions of the same basic algorithms and software.12
Called "dual licensing" or "versioning," this dual release strategy is
Benkler, Coase's Penguin, or, Linux and The Nature of the Firm, 112 Yale L J 369, 411-12
(2002); McGowan, 2001 U Ill L Rev at 250-53 (cited in note 3).
9 See Karim R. Lakhani and Eric von Hippel, How Open Source Software Works: "Free"
User-to-User Assistance, 32 Rsrch Pol 923, 936-37 (2003) (finding that programmers post an-
swers to open-source questions because they have benefitted from the answers in the past or
expect to in the future).
10 See Eilhard, Open Source Incorporated at *15, 26-27 (cited in note 4).
11 See Affymetrix, GeneChip-Compatible Software Providers, online at http://www.
affymetrix.com/estore/partnersprograms/genechip-compatible/genechip-compatible.affx (visited
Oct 19,2010).
12 A full list of both open-source and proprietary algorithms is provided in Appendix A. The
open-source algorithms are released under a variety of different licenses. Bioconductor is released
under version 2 of the GNU Public License (GPL 2), which requires the user to release the source
code for any modifications to others without charge. GNU, General Public License, Version 2,
online at http://www.gnu.org/licenses/gpl-2.0.html (visited Oct 19, 2010). dChip, by contrast, is
released under a looser standard that seems to approach freeware; the source code is made availa-
ble, and the license says that "if you build a Unix or Linux version, we will appreciate it if you can
share the codes or binaries or be linked from this page." dChip: Introduction and Installation,
online at http://biosunl.harvard.edu/complab/dchip/install.htm (visited Oct 19, 2010). On the be-
wildering array of open-source and related licenses, see Robert W. Gomulkiewicz, Open Source
License Proliferation: Helpful Diversity or Hopeless Confuision?, 30 Wash U J L & Pol 261, 264-77
(2009). See also Robert W. Gomulkiewicz, Conditions and Covenants in License Contracts: Tales
from a Test of the Artistic License, 17 Tex Intel Prop L J 335, 337-39 (2009).
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increasingly common in the open-source software environment.
Affymetrix provides parallel software in two different versions be-
cause it believes that some users will want the low cost of open-source
software, while some private firms will want to improve on the soft-
ware or add their own proprietary extensions without being subject to
the obligation to release those extensions under an open-source li-
cense. This provides a natural test of customer selection of open-
source or proprietary software."
To test those usage patterns, we conducted two studies. First, we
reviewed publications from Affymetrix's "Scientific Publications"
page for the period from 2007 to 2008." In all, we found 178 publica-
tions that make reference to algorithms of software for interpreting
data from the Affymetrix GeneChip. We collected data on the entity
status of each author, and on the algorithm and the software those
authors used. When users write papers disclosing results made using
the GeneChip, they almost always cite the software they relied on to
generate those results." As a result, we can learn about usage patterns
by observing publication patterns.
Those usage patterns will be biased, however, because they rep-
resent not all users of Affymetrix GeneChips but only those who pub-
lish their results. That group is likely to include disproportionate
numbers of academic and nonprofit users. And indeed we find in the
next Part that most publishers are academics. To ensure that private
firm users are represented, we oversampled commercial users in the
publication search. Publication also cannot account for intensity of
use, though there should be some relationship between the two: those
who use the chip to make a publishable discovery are likely to be
13 See Stefano Comino and Fabio M. Manenti, Dual Licensing in Open Source Software
Markets *3-4 (unpublished manuscript, Jan 2010), online at http://ssrn.com/abstract=985529
(visited Oct 19, 2010); Robert W. Gomulkiewicz, Entrepreneurial Open Source Software Hack-
ers: MySQL and Its Dual Licensing, 9 Computer L Rev & Tech J 203, 208-11 (2004).
14 The test is not perfect, because the algorithms and software implementing those algo-
rithms are not identical. First, we note that the algorithms and the software are not necessarily
independent variables. For example, MAS 5.0 does not run the RMA algorithm, and
GeneSpring does not run the MAS algorithm. As a result, some users might have chosen their
software based on the algorithms rather than the open-source or proprietary issues. Second,
since we study Affymetrix microarrays, our study sample is naturally biased toward users who
have a greater propensity to choose the Affymetrix GCOS or MAS 5.0 software than do people
buying Illumina microarrays. Notwithstanding these limitations, the programs are used for the
same purpose, written by the same people, and have significant similarities.
15 For a full discussion of how those sources were selected, see Appendix B.
16 This is confirmed by survey data: 95.4 percent of academic users, 90.9 percent of other
nonprofit users, and 80 percent of private firms who wrote a paper using the results cited the
software in that paper. Overall, 250 of 270 survey respondents who published papers, or
92.6 percent, cited the software by name in the paper. For the original survey question, see Ap-
pendix C, question 14.
142 [78:139
Who Chooses Open-Source Software?
more intensive users than those who do not, all other things being
equal. Still, this is a limitation of the publication data.
To explore the motivations of users and the uses they make of
the software, we supplement the literature search with a survey of
users of the Affymetrix GeneChip. We sent out surveys to a wide
range of individuals who have used the Affymetrix software and re-
ceived 437 complete and usable responses." Of the 437 respondents,
305 (or 69.8 percent) were academics, 52 (or 11.9 percent) were non-
profit entities, and 80 (or 18.3 percent) were at private firms. The re-
sults indicate a predominance of academic users, but not surprisingly
include more private firms than did the publication search.
III. RESULTS
A. Publication Data
For each published article, we studied the nature of the authors
(academic, nonprofit, commercial, or mixed); if commercial, the in-
dustry (biotechnology or pharmaceuticals) in which the authors
worked; whether the authors were domestic or foreign; and whether
they used commercial or open-source software. We excluded from
consideration review articles or meta-analyses in which the authors
were not themselves running the experiments in which the data were
collected, as well as articles that did not specify the software used. The
summary results are presented in Table 1.
17 This represents a response rate below 50 percent, but given that the survey was sent by
email and without a follow-up, that rate is not abnormally low.
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TABLE 1. DESCRIPTIVE STATISTICS FOR PUBLICATIONS
Category Number
Total papers 178
Academic papers 110
Nonprofit papers (including government) 11
Commercial papers 55
Commercial biotech 14
Commercial pharma 41
*
Joint academic-commercial papers 8
Papers by US authors 116
Papers by foreign authors 62
Open-source algorithms/software 35
Proprietary algorithms/software 148
* When there were joint papers, we included them in either the commercial or academic
category, but not both. We made this assessment based on who the lead author was and
which side had the greater number of authors. Of the joint papers, six were primarily by
academic authors and two were primarily commercial.
** As with joint authors, we treated papers as primarily either US or foreign
in authorship.
In Table 2, we explore how different actors vary in their use of
open-source and proprietary software.
TABLE 2. USAGE OF OPEN-SOURCE SOFTWARE
BY AUTHOR CHARACTERISTICS
Proprietary Open-Source
Author Category Cites* Cites
Academic papers 85 (77%) 31 (28%)
Nonprofit papers 9(82%) 2(18%)
Commercial papers 54 (96%) 2 (4%)
Commercial biotech 13 (93%) 1 (7%)
Commercial pharma 41 (100%) 1 (2%)
Joint academic- 7 (88%) 2 (25%)
commercial papers
US authors 106(91%) 24(22%)
Foreign authors 52 (84%) 13 (21%)
* Some authors cited both open-source and proprietary software, so the percentages
may exceed 100 percent.
The difference between academic and commercial users of open-
source software is dramatic. The results are depicted in Figure 1.
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FIGURE 1. SOFTWARE USAGE OF ACADEMIC VERSUS
COMMERCIAL USERS
73.0% .
96.0%
Academic Users Commercial Users 4.0%
27.0%
[ Proprietary Software Cites [] Open-Source Software Cites
The publication data suggest that academic users are far more
likely to use open-source software than commercial entities; only a
very small percentage of commercial users made use of open-source
software, and half of those did so in the course of academic-
commercial collaborations.
One possible explanation for this result is that commercial users
want to release products using or incorporating the GeneChip software
and charge for those products, something open-source licenses would
restrict." We investigate that possibility in the next Part. Relatedly,
commercial users may be worried about the risk of legal entanglement
that comes with open-source software even if they are not now plan-
ning to release a product that incorporates that software. Another pos-
sibility is that commercial users expect proprietary software to be supe-
rior, with additional features or better usability, and are more willing
than academic users to pay for that additional functionality.
B. Survey Data
With the assistance of Affymetrix, we surveyed users of Affymet-
rix GeneChips. We asked survey respondents a variety of questions,
including which algorithms and which software they used, whether
they were aware of other software, why they chose the version they did,
whether they provided bug reports or fixes, whether they modified or
improved the software, whether they released those modifications and
18 Exactly what form this restriction takes is a complicated question. A few open-source
licenses, such as the BSD license, do not prevent licensees from charging for products. The GPL
and related licenses, strictly speaking, allow the licensee to charge for products made using the
license, but they also require that the code be made available for free, which makes the collec-
tion of revenue more difficult.
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if so to whom, and whether they published their results." We can
sort these results on the answer to any previous question; in much of
what follows, we distinguish between those who used open-source
software and algorithms and those who used proprietary software
and algorithms.
We begin by replicating the analysis from the publication survey,
measuring academic, nonprofit, and commercial users and users of open-
source or proprietary software. The results appear in Tables 3 and 4.
TABLE 3. DESCRIPTIVE STATISTICS FOR SURVEY DATA
Category Number
Total respondents
Academic respondents
Nonprofit respondents
Commercial respondents
442*
305 (68.1%)
52 (11.7%)
80 (17.9%)
Respondents using open-source 251 (5
algorithms/software
Respondents using proprietary 369 (8
algorithms/software
Five respondents did not fit into one of the listed categories.
7.4%)
4.4%)
TABLE 4. USAGE OF OPEN-SOURCE SOFTWARE BY
AUTHOR CHARACTERISTICS
Author Category
Proprietary
Uses
Open-Source
Uses
Academic users
Nonprofit users
Commercial users
245 (68.6%)
43 (12.0%)
62 (17.4%)
174 (71%)
25 (10.2%)
43 (17.6%)
* N = 357; 12 did not answer the question. Of the 357, 7 (2.0 percent) were independent
or reported no affiliation.
** N = 245; 6 did not answer the question. Of the 245, 3 (1.2 percent) were independent or
reported no affiliation.
19 The complete list of questions is attached as Appendix C.
20 We included Bioconductor and dChip in the open-source category and Stratagene Ar-
rayAssist, Stratagene ArrayAssist Lite, Rosetta Resolver, GeneChip Operating System
(GCOS), GeneSpring, Affymetrix Power Tools, Affymetrix Expression Console, Microarray
Suite (MAS), and Spotfire in the proprietary category. There was also a survey option of "Oth-
er," in which the vast majority of people listed other less well-known proprietary software-
these answers were included in the "proprietary" category.
We also had many users who used both open-source and proprietary software and algo-
rithms. As a general matter, we have included joint users in both the open-source and proprie-
tary software categories, but at various points we have separated them into their own group. We
note that in Table 5.
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Curiously, the data here show no similar distinction between aca-
demic and commercial users. Indeed, commercial users made up the
same percentage of users of both open-source and proprietary soft-
ware. And we were unable to reject the hypothesis that each type of
user was equally likely to use open-source or proprietary software.2
We do find modest differences in the stated reasons why people
employed particular programs. Those who used proprietary software
gave the following answers:
Why did you choose the version you did? [check all that apply]
Response Response
Answer Options Frequency Count
It was compatible with/used the desired 67.4% 225
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper 35.0% 117
It gave me greater freedom to modify 29.6% 99
the software
It was more reliable 30.8% 103
It was more convenient 37.7% 126
It had better support 22.5% 75
My institution already had a license to it 30.2% 101
Other 9.6% 32
If "Other," please explain in your own 41
words why you chose the version you did:
Answered question 334
Skipped question 35
21 The statistical tests are available from the authors upon request.
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By contrast, those who used open-source software gave the fol-
lowing answers:
Why did you choose the version you did? [check all that apply]
Response Response
Answer Options Frequency Count
It was compatible with/used the desired 74.6% 176
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper 47.5% 112
It gave me greater freedom to modify 42.4% 100
the software
It was more reliable 31.8% 75
It was more convenient 34.7% 82
It had better support 21.6% 51
My institution already had a license to it 23.7% 56
Other 7.2% 17
If "Other," please explain in your own 24
words why you chose the version you did:
Answered question 236
Skipped question 15
There are some differences here that line up with expectations-
users of open-source software put more emphasis on cost (47.5 versus
35 percent) and on ability to modify the software (42.4 versus
29.6 percent), for instance. But the overall differences are surprisingly
modest. Indeed, differences between respondents' answers to the cost
and ability to modify questions are the only ones that are statistically
significant at a 99 percent confidence level.'
We also find modest differences in the use people make of the dif-
ferent types of software. For example, users of open-source software
were marginally more likely to send fixes or bug reports back to the
software developers. Among open-source users, 42.3 percent provided
bug reports, compared with 37.8 percent of proprietary software users;
23.5 percent of open-source users improved the software, compared
with 19.1 percent of proprietary users. Fifty percent of the open-source
users who modified the software released that software to others, com-
pared with 45.6 percent of those who modified proprietary software.
22 With only 90 percent confidence, we can say that users preferred open-source software
because it was compatible with what they already used, and proprietary software if their firm
already had a license to it.
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One reason the data appear so noisy may be that these measures
include a significant number of users who employed both open-source
and proprietary GeneChip software at different times. This is the most
logical way to explain the result that 35 percent of users of proprietary
software stated "lower cost" as a reason for choosing the software they
did, for example.' As a result, we also report a restricted sample limited
to those who used only open-source or only proprietary software.'
The results of the restricted sample are more consistent with our
expectations. We report the descriptive statistics in Table 5. We em-
phasize, however, that the restricted sample is smaller and that none
of these differences is statistically significant.
TABLE 5. USAGE OF SOLELY OPEN-SOURCE OR PROPRIETARY
SOFTWARE BY AUTHOR CHARACTERISTICS
Solely Proprietary Solely Open-
Author Category Uses* Source Uses"
Academic users 114 (64.8%) 33 (73.3%)
Nonprofit users 22 (12.5%) 4 (8.9%)
Commercial users 34 (19.3%) 8 (17.8%)
* N = 185; 9 did not answer the question. Of the 185, 6 (3.2 percent) were independent or reported no
affiliation.
* N = 47; 2 did not answer the question.
The differences between the reasons users offer for choosing
solely open-source or proprietary software, by contrast, are more pro-
nounced in the restricted sample. Respondents who used only open-
source software gave the following answers:
23 It is also possible that some users considered proprietary software cheap because their
institution already owned a license to it, but that should at most equalize the cost vis-A-vis open-
source software.
24 This restricted sample will of necessity exclude those who switched from proprietary to
open-source software (or, more problematically, from open-source to proprietary software)
during the time of the study. See Greg R. Vetter, Commercial Free and Open Source Software:
Knowledge Production, Hybrid Appropriability, and Patents, 77 Fordham L Rev 2087, 2129-31
(2009) (discussing examples of companies that switch modes).
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Why did you choose the version you did? [check all that apply]
Response Response
Answer Options Frequency Count
It was compatible with/used the desired 64.9% 24
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper 64.9% 24
It gave me greater freedom to modify 54.1% 20
the software
It was more reliable 27.0% 10
It was more convenient 18.9% 7
It had better support 16.2% 6
My institution already had a license to it 2.7% 1
Other 2.7% 1
If "Other," please explain in your own 2
words why you chose the version you did:
Answered question 37
Skipped question 10
By contrast, those who used only proprietary software gave the
following answers:
Why did you choose the version you did? [check all that apply]
Response Response
Answer Options Frequency Count
It was compatible with/used the desired 53.9% 83
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper 21.4% 33
It gave me greater freedom to modify the 16.9% 26
software
It was more reliable 28.6% 44
It was more convenient 37.7% 58
It had better support 23.4% 36
My institution already had a license to it 32.5% 50
Other 16.2% 25
If "Other," please explain in your own 30
words why you chose the version you did:
Answered question 154
Skipped question 31
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Both sets in the restricted sample emphasized compatibility as
a strong factor in software choice, suggesting a fair degree of path
dependence driving the results. Open-source software users were
more likely to emphasize the lower cost (64.9 versus 21.4 percent) and
freedom to modify their software (54.1 versus 16.9 percent); proprie-
tary software users were more likely to point to an existing institu-
tional license (32.5 versus 2.7 percent) and the convenience of the
software (37.7 versus 18.9 percent).'
We also find modest differences in the use people make of the
different types of software in our restricted sample. We report those
differences in Table 6.
TABLE 6. BUG REPORTING AND SOFTWARE IMPROVEMENT
DIFFERENCES BETWEEN OPEN-SOURCE
AND PROPRIETARY USERS
Proprietary Open-Source
Type of Usage Users Users
Reported bugs or sent fixes 32.8% 35.6%
Improved the software 16.4% 22.2%
Released modified software 48.3% 60.0%
to others
Differences between open-source and proprietary users are not statistically significant in any of the
categories.
Users of open-source software were not appreciably more likely
to send fixes or bug reports back to the software developers-
35.6 percent of open-source users provided bug reports, compared
with 32.8 percent among proprietary software users; 22.2 percent of
open-source users improved the software, compared with 16.4 percent
of proprietary users. Sixty percent of the open-source users who modi-
fied the software released that software to others, compared with
48.3 percent of those who modified proprietary software. As with the
unrestricted sample, the differences are surprisingly modest, and none
is statistically significant.
This is a curious result. Under the general terms of open-source
software licenses, those who modify or contribute new software that
they sell or distribute must make their new or modified code available
to others. There might be an argument that open-source rules do not
require that the source code be publicly distributed at all but simply
25 The "cheaper," "freedom to modify," and "license" answers are statistically significant
at the 99 percent confidence level; the "convenience" answer is significant at the 95 percent
confidence level.
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provided on request.6 But even so, we find that most open-source us-
ers who released improved software did so only to their own custom-
ers (67.9 percent in the unrestricted sample; 83.3 percent in the re-
stricted sample), despite the presumed obligation to make the code
available to anyone who wanted it. Those who did release the soft-
ware improvements usually did so under their own brand names-
78.6 percent for open-source users (100 percent in the restricted sam-
ple) and 72.4 percent for proprietary software users (61.5 percent in
the restricted sample).
Interestingly, the rationale that drove Affymetrix to release parallel
programs in both open-source and proprietary formats-the belief that
customers would want proprietary software because they hoped to im-
prove on it and sell the improvement-does not appear to be borne out
in the data. Some users of both open-source and proprietary software
modified the software and released their modifications to the public
as products. Users of open-source software were slightly more likely
to modify the program than users of proprietary software. They were
marginally more likely to release that software to the public, and mar-
ginally more likely to brand that improved software with their own
mark. Again, however, we note that these differences are modest and
not statistically significant.
IV. IMPLICATIONS
What stand out in these results are not the differences between
open-source and proprietary software users but the similarities. Users
of the probe-set summarization and normalization software seem
largely indifferent to whether the software they use is open-source or
proprietary. They often use multiple programs and algorithms, some
of which are open source and some of which are proprietary. That sort
of mixing is a big worry for open-source lawyers; indeed, there are
companies designed to audit software code to make sure there is no
inappropriate mixing.' Mixing is relevant primarily for those who
change or improve code, not for passive users. But we find that rough-
ly a quarter of users, including many users of both open-source and
proprietary software, do in fact improve the software and release their
26 The GPL 2 provides that "[y]ou must make sure that [recipients], too, receive or can get
the source code." GNU, General Public License, Version 2 (cited in note 12). This could be
satisfied by a distribution on request. And the BSD license does not impose that constraint.
27 See, for example, Black Duck Software, Multi-source Development with Open Source
Software, online at http://www.blackducksoftware.com/multisourcedevelopment (visited Oct 20,
2010); Gomulkiewicz, 9 Computer L Rev & Tech J at 207, 210-11 (cited in note 13).
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improvements to others.' Curiously, even these improvers seem large-
ly indifferent to the open-source-proprietary line, to the extent that
many of them appear to be ignoring the fundamental constraint of
open-source software-that you release your improvements to every-
one. In fact, it is not clear that they are even aware of the limits on
behavior that open-source licenses impose.
This is a small study in a single industry, one in which the users
are not primarily computer programmers. Further research may re-
veal whether our conclusion is merely an artifact of our study uni-
verse, whether similar behavior exists in more traditional open-source
software contexts, or whether the result is driven by the fact that users
outside the central open-source community have not fully internalized
the norms of open-source software. More study is required.'
But if our results are generalizable, they have a broader implica-
tion: to bring to bear the "law in action" literature to the open-
source-proprietary divide. While the law-and the intent of the open-
source movement-draws a sharp distinction between open-source
and proprietary software, placing them effectively in different worlds,
users of the software in bioinformatics appear to observe no such
sharp distinction. They appear to employ a mix of open-source and
proprietary software tools chosen for a variety of reasons, not merely
or even primarily for their openness or appropriability. And they
seem to use those software tools as they will-and not as the niceties
of open-source contracts would suggest. Law may matter to makers of
open-source software, but it does not appear to affect the behavior of
software users.
28 Other studies have found even higher rates of hybrid software use. See The 451 Group,
Executive Overview: Open Source Is Not a Business Model: How Vendors Generate Revenue
from Open Source Software *1 (Oct 2008), online at http://www.the451group.com/reports/
executivesummary.php?id=694 (visited Oct 31, 2010) (finding that 50 percent of open-source
software vendors use a hybrid model); Eilhard, Open Source Incorporated at *26-27 (cited in
note 4) (finding that nearly half of open-source programmers are paid for their work).
29 Others have surveyed computer programmers in more traditional software industries.
See, for example, Sujoy Chakravarty, Eman Haruvy, and Fang Wu, The Link between Incentives
and Product Performance in Open Source Development: An Empirical Investigation, 9 Global
Bus & Econ Rev 151, 159-60 (2007); Guido Hertel, Sven Niedner, and Stefanie Herrmann,
Motivation of Software Developers in Open Source Projects: An Internet-Based Survey of Con-
tributors to the Linux Kernel, 32 Rsrch Pol 1159, 1166 (2003); Sharon Belenzon and Mark
Schankerman, Motivation and Sorting in Open Source Software Innovation *21-24 (unpublished
manuscript, Oct 2008), online at http://ssrn.com/abstract=1401776 (visited Oct 20, 2010). And
one study measured open-source adoption in hospitals. See Gilberto Munoz-Cornejo, Carolyn
B. Seaman, and A. Giine§ Koru, An Empirical Investigation into the Adoption of Open Source
Software in Hospitals, 3 Intl J Healthcare Info Sys & Informatics 16, 26 (July-Sept 2008).
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This in turn inclines us to a policy of legal neutrality with regard
to open-source and proprietary software.' Open-source software is
not "better" than proprietary software, nor the reverse. Users want-
and should have-the freedom to choose the right software for their
particular purposes. But legal scholars need to understand that those
users are often less concerned with the niceties of software licenses
than with using whatever tool seems best suited to the job at hand.
William Gibson famously said that "the street finds its own uses for
things."" The same, it seems, can be said of technology licenses.
30 See generally Robert W. Hahn, ed, Government Policy toward Open Source Software
(Brookings 2002).
31 William Gibson, Burning Chrome, in William Frucht, ed, Imaginary Numbers: An Anthol-
ogy of Marvelous Mathematical Stories, Diversions, Poems, and Musings 195, 212 (Wiley 1999).
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APPENDIX A. LIST OF PROGRAMS AND ALGORITHMS STUDIED
Algorithms Software
Proprietary Open Source
MAS 5.0 Microarray Analysis Bioconductor
Suite 5.0 (MAS 5.0)
RMA/GC-RMA GeneChip Operating dChip
System (GCOS)
PLIER GeneSpring
Rosetta Resolver Affymetrix Power
Tools
Affymetrix Expression
Console
Stratagene ArrayAssist
Stratagene ArrayAssist
Lite
Rosetta Resolver
Spotfire
Other
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APPENDIX B. METHODOLOGY FOR IDENTIFYING
RELEVANT PUBLICATIONS
We analyzed scientific publications to identify the software used
to conduct primary probe-set summarization on Affymetrix Expres-
sion Analysis GeneChips. Probe-set summarization refers to the step
of calculating raw expression data from the scanned image of a micro-
array. A publication was said to have used a particular software pack-
age if it was clear that probe-set summarization was being performed
by the software in question. All other data-analysis steps such as nor-
malization were not considered in deciding which software was used.
The following information was captured for each of the publica-
tions:
* Year of publication
* Article name
* Journal name
* Number of authors cited
* Number of different departments and institutions cited
* Primary location of the authors
* Whether the publication was from an academic source, an
NGO, a commercial company, or a combination
* If the publication was from a company, then which industry
that company is in (either pharma or biotech)
* Whether the software cited was proprietary or open source
* The name of the company releasing the software
* The name of the particular software
A. Academic Publications
Academic publications were randomly chosen in the following
fashion: As of the time we collected the data in 2009, the complete list
of publications that cite Affymetrix are listed on the Affymetrix web-
site, by year, under the "Scientific Publications" page. Publications
are displayed in groups of nine for any particular year.
Using the random number generator from www.random.org, a
random number from one through nine was produced, which would
correspond to a publication in the group of nine, with one denoting
the publication on top, and nine denoting the publication on the bot-
tom. There were 3,622 total publications in 2007, on a total of 363 dif-
ferent pages displaying groups of nine publications for each page.' At
32 For a complete list, see Affymetrix, Results, online at http://www.affymetrix.comlestore/
publications/pub-query-result.affx?year=2007 (visited Jan 16,2011).
156 [78:139
Who Chooses Open-Source Software?
first an article from each page was chosen, but by page 50, the selec-
tion switched to choosing articles only from odd-numbered pages.
In total, we analyzed 203 academic publications. Of these, 121
proved useable for analysis. The rest were left out of the analysis be-
cause they:
* were not accessible;
* did not explicitly specify the software they were using to get
probe-set summarization data;
* were review articles or were meta-analyses of others' data, ra-
ther than reports of primary use of GeneChips; or
* were not using Affymetrix "Expression Analysis Arrays."
B. Commercial Publications
We also analyzed publications from commercial companies. For
commercial publications, we obtained a list of all of the scientific pub-
lications that cited Affymetrix in 2007 and 2008 from Martha Manion,
head librarian of Affymetrix. This list denotes which publications are
from commercial entities. As a result, we collected all publications by
commercial entities, ensuring that there was not a selection bias in
choosing the commercial publications. In total, we analyzed 110 publi-
cations; of these, 55 proved usable for analysis. We analyzed only pub-
lications by authors solely from commercial companies; no academic-
commercial combinations were analyzed in this particular round of
analysis. The exclusion criteria used for academic publications also
applied here.
A full list of publications studied is available from the authors
upon request.
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APPENDIX C. LIST OF SURVEY QUESTIONS
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1. Do you use software algorithms to summarize the probe set and/or nor-
malize raw expression data from Affymetrix GeneChips? These are the
steps in GeneChip analysis that turn raw intensity data (.CEL files) into
expression signal values (e.g., .CHP files) that can be compared from micro-
array to microarray for further analysis.
Answer Options Response Frequency Response Count
Yes
No
2. Are you the person within your organization who decided which algo-
rithm and software to use to summarize and/or normalize raw expression
data?
Response Response
Answer Options Frequency Count
Yes
No
If "No," please tell us who within your organi-
zation made that decision (contact infor-
mation is most appreciated)
3. Which of the following algorithms have you used for probe-set summari-
zation or normalization of Affymetrix GeneChip data? [check all that apply]
Response Response
Answer Options Frequency Count
Microarray Analysis Suite (MAS 5.0 or
MAS 4.0)
RMA/GC RMA
PLIER
Rosetta Resolver
None
I don't know
Other
If "Other," please list the algorithms here
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4. Which of the following software programs have you used for probe-set
summarization or normalization of Affymetrix GeneChip data? [check all
that apply]
Response Response
Answer Options Frequency Count
dChip
Bioconductor
Stratagene ArrayAssist
Stratagene ArrayAssist Lite
Rosetta Resolver
GeneChip Operating System (GCOS)
GeneSpring
Affymetrix Power Tools
Affymetrix Expression Console
Microarray Suite
Spotfire
I don't know
None [if you answered "none" to both ques-
tions 3 and 4, please skip to the end of the
survey]
Other
If "Other," please list the software programs
here
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5. What do you use the software for? [If different software is used for dif-
ferent steps, please choose the appropriate package used most often in the
right-most column]
Check "Yes" if you use software cited in Question 4 for this function
IYes
Probe-set
summarization
only
__ 1 _______
Normalization
of data only
Both probe-set
summarization
and normaliza-
tion
Background
subtraction
Plotting and
analysis
Further down-
stream analysis
(clustering, fold
change analy-
sis, etc.)
Other
I don't know
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Other software used for this particular function
c i
0
U
00
0
'A) CA 0 0
. 0 ) 0 0
4u C0 4 u4 - 4
of dat only
0 4 ) 4) U 0u
Apnse U P4 Cu 0 < El)
Probe-set sum-
marization only
Normalization
of data only
Both probe-set
summarization
and normaliza-
tion
Background
subtraction
Plotting and
analysis
Further down-
stream analysis
(clustering, fold
change analysis,
etc.)
Other
I don't know
6. Were you aware of the existence of different software programs that
served these purposes?
Answer Options Response Frequency Response Count
Yes
No
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7. Why did you choose the version you did? [check all t at apply]
Response Response
Answer Options Frequency Count
It was compatible with/used the de-
sired processing algorithm (such as
RMA, GC-RMA, MAS 5.0)
It was cheaper
It gave me greater freedom to modify
the software
It was more reliable
It was more convenient
It had better support
My institution already had a license to
it
Other
If "Other," please explain in your own
words why you chose the version you
did:
8. Have you provided reports of bugs or other problems with summari-
zation or normalization software since you began using it?
Response Response
Answer Options Frequency Count
Yes
No
9. Have you modified or improved summarization or normalization
software since you began using it?
Response Response
Answer Options Frequency Count
Yes
No
If you answered "Yes," please briefly
describe how you modified it:
10. If so, did you release that modified version to others outside your
organization?
Answer Options Response Frequency Response Count
Yes
No
I
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11. If so, did you release the modified version under your own brand
name, or under the original publisher's brand name?
Answer Options Response Frequency Response Count
Our own
Original publisher
12. Who did you market, sell, or give the modified version to?
Answer Options Response Frequency Response Count
Our existing clients or
partners only
Anyone who wanted it
13. Have you published results based on research you did using microar-
ray analysis software?
Answer Options Response Frequency Response Count
Yes
No
14. If so, did you cite the software by name?
Answer Options Response Frequency Response Count
Yes
No
15. Are you at an academic research institution or a for-profit company?
Answer Options Response Frequency Response Count
Academic institution
Other nonprofit entity
Private company
Independent/no affilia-
tion
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16. Which role or roles best define your usage of Affymetrix GeneChips?
Answer Options Response Frequency Response Count
I am the primary user of the
chip, seeing the work
through from when the
GeneChip is first used in an
experiment to when it is
analyzed
I use the GeneChip in my
experiments, but outsource
the analysis of it to a third
party (ex. a core facility)
I conduct the GeneChip
analysis for other people's
experiments (ex. worker at a
core facility)
I don't use GeneChips my-
self; I extract GeneChip
data from other sources
(such as the Gene Expres-
sion Omnibus) and analyze
that
I utilize microarray data
and/or microarray analysis
programs to develop my
own software tools, which I
then market to outside par-
ties
I utilize microarray data
and/or microarray analysis
programs to develop my
own software tools, which I
then release under an open
source license
I utilize microarray data
and/or microarray analysis
programs to develop my
own software tools, which I
then use only internally I
I have no association with
GeneChips or their data
17. If you would like to be entered into a drawing for an iPod Touch,
then please enter your information below. All identifying information
entered will be kept anonymous and separate from the survey responses.
Answer Options Response Frequency Response Count
Name
Email
Phone Number
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